Unigestion Holding’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-91,867
Closed -$2.95M 185
2023
Q3
$2.95M Sell
91,867
-16,993
-16% -$601K 0.18% 82
2023
Q2
$3.93M Sell
108,860
-1,784
-2% -$69.4K 0.23% 71
2023
Q1
$4.47M Sell
110,644
-8,831
-7% -$381K 0.24% 71
2022
Q4
$6.13M Sell
119,475
-22,689
-16% -$1.09M 0.33% 68
2022
Q3
$6.28M Sell
142,164
-10,976
-7% -$533K 0.36% 61
2022
Q2
$8.03M Buy
153,140
+2,426
+2% +$124K 0.45% 54
2022
Q1
$7.8M Sell
150,714
-11,843
-7% -$614K 0.33% 57
2021
Q4
$9.6M Sell
162,557
-38,488
-19% -$1.91M 0.39% 59
2021
Q3
$8.65M Sell
201,045
-26,915
-12% -$1.19M 0.35% 55
2021
Q2
$8.91M Sell
227,960
-66,881
-23% -$2.6M 0.32% 61
2021
Q1
$10.7M Sell
294,841
-45,079
-13% -$1.6M 0.38% 59
2020
Q4
$12.5M Sell
339,920
-185,074
-35% -$6.79M 0.43% 48
2020
Q3
$18.3M Sell
524,994
-930,552
-64% -$32.6M 0.63% 45
2020
Q2
$45.1M Sell
1,455,546
-123,569
-8% -$4.2M 1.52% 22
2020
Q1
$48.9M Buy
+1,579,115
New +$53.8M 1.82% 18
2019
Q3
$24.6M Buy
721,986
+16,120
+2% +$586K 0.68% 48
2019
Q2
$29M Buy
705,866
+88,683
+14% +$3.52M 0.77% 52
2019
Q1
$24.9M Sell
617,183
-455,586
-42% -$18.2M 0.66% 53
2018
Q4
$44.4M Sell
1,072,769
-311,469
-23% -$12.9M 1.12% 27
2018
Q3
$57.9M Sell
1,384,238
-217,275
-14% -$8.36M 1.22% 21
2018
Q2
$55.1M Buy
+1,601,513
New +$54.7M 1.09% 23

Other funds holding PFE

Unigestion Holding's PFE Position: Q4 2023 in Review

Unigestion Holding sold out of Pfizer (PFE) in Q4 2023, closing a stake of 91,867 shares — an estimated $2.95M sold.

Unigestion Holding first reported a position in PFE in Q2 2018 and held it in 21 quarters. The position peaked at $57.9M in Q3 2018. 2,935 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

  • Unigestion Holding reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
  • Unigestion Holding sold 91,867 Pfizer shares in Q4 2023, an estimated $2.95M.
  • Unigestion Holding first reported a position in Pfizer in Q2 2018 and held it in 21 quarters.
  • Unigestion Holding's Pfizer position peaked at $57.9M in Q3 2018.
  • 2,935 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on Unigestion Holding's 13F filing for Q4 2023, filed 14 Feb 2024.